[Mild Neurocognitive Disorder - a Disease? Against]
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
[Dementia - View of sufferers and their relatives].
Schaub R, von Lutzau-Hohlbein H Z Gerontol Geriatr. 2017; 50(7):616-622.
PMID: 28993868 DOI: 10.1007/s00391-017-1311-6.
References
1.
Buchhave P, Minthon L, Zetterberg H, Wallin A, Blennow K, Hansson O
. Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry. 2012; 69(1):98-106.
DOI: 10.1001/archgenpsychiatry.2011.155.
View
2.
Frisoni G, Hampel H, OBrien J, Ritchie K, Winblad B
. Revised criteria for Alzheimer's disease: what are the lessons for clinicians?. Lancet Neurol. 2011; 10(7):598-601.
DOI: 10.1016/S1474-4422(11)70126-0.
View
3.
Jack Jr C, Knopman D, Jagust W, Petersen R, Weiner M, Aisen P
. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013; 12(2):207-16.
PMC: 3622225.
DOI: 10.1016/S1474-4422(12)70291-0.
View
4.
Damian M, Hausner L, Jekel K, Richter M, Froelich L, Almkvist O
. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study. Dement Geriatr Cogn Disord. 2013; 36(1-2):1-19.
DOI: 10.1159/000348354.
View
5.
Visser P, Verhey F
. Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria. Psychol Med. 2007; 38(1):113-22.
DOI: 10.1017/S0033291707000554.
View